Nuvalent Highlights Upcoming Data Presentations for Neladalkib and Zidesamtinib at the 2026 American Society of Clinical Oncology Annual Meeting
Go back to Nuvalent Highlights Upcoming Data Presentations for Neladalkib and Zidesamtinib at the 2026 American Society of Clinical Oncology Annual Meeting| Nuvel Holdings, Inc. (NASDAQ: NUVL) | Delayed: 123.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.44 | 52 Week High | $0.40 | |||
| Open | $123.44 | 52 Week Low | $0.14 | |||
| Day High | $123.44 | P/E | N/A | |||
| Day Low | $123.44 | EPS | $-0.56 | |||
| Volume | 1,000 | |||||
